Add to ORKGEffects of the oral, direct thrombin inhibitor dabigatran on five common coagulation assay
Dabigatran, a direct thrombin inhibitor, is increasingly used clinically as one of the new oral anti...
Dabigatran etexilate, a pro-drug of a direct thrombin inhibitor, was approved a few years ago for no...
Background Direct oral anticoagulants (DOACs) are increasingly replacing vitamin K antagonists (VKA)...
Dabigatran is an oral, reversible thrombin inhibitor that has shown promising results in large clini...
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagul...
The Belgian national External Quality Assessment Scheme performed a nationwide survey using lyophili...
Dabigatran (DAB) is an orally administered thrombin inhibitor. Both DAB and its main metabolite dabi...
The Belgian national External Quality Assessment Scheme performed a nationwide survey using lyophili...
The Belgian national External Quality Assessment Scheme performed a nationwide survey using lyophili...
Thrombin, the key effector protease of the coagulation cascade, drives fibrin deposition and activat...
The Belgian national External Quality Assessment Scheme performed a nationwide survey using lyophili...
The ability of Staphylococcus aureus to clot plasma through conformational activation of prothrombin...
<p class="rtejustify">The Belgian national External Quality Assessment Scheme perfor...
Thromboembolic disease is a major cause of mortality and morbidity in the developed world and is cau...
BACKGROUND: The anticoagulant effect of dabigatran can be approximated by its prolongation of routin...
Dabigatran, a direct thrombin inhibitor, is increasingly used clinically as one of the new oral anti...
Dabigatran etexilate, a pro-drug of a direct thrombin inhibitor, was approved a few years ago for no...
Background Direct oral anticoagulants (DOACs) are increasingly replacing vitamin K antagonists (VKA)...
Dabigatran is an oral, reversible thrombin inhibitor that has shown promising results in large clini...
Dabigatran etexilate – a novel, reversible, oral direct thrombin inhibitor: Interpretation of coagul...
The Belgian national External Quality Assessment Scheme performed a nationwide survey using lyophili...
Dabigatran (DAB) is an orally administered thrombin inhibitor. Both DAB and its main metabolite dabi...
The Belgian national External Quality Assessment Scheme performed a nationwide survey using lyophili...
The Belgian national External Quality Assessment Scheme performed a nationwide survey using lyophili...
Thrombin, the key effector protease of the coagulation cascade, drives fibrin deposition and activat...
The Belgian national External Quality Assessment Scheme performed a nationwide survey using lyophili...
The ability of Staphylococcus aureus to clot plasma through conformational activation of prothrombin...
<p class="rtejustify">The Belgian national External Quality Assessment Scheme perfor...
Thromboembolic disease is a major cause of mortality and morbidity in the developed world and is cau...
BACKGROUND: The anticoagulant effect of dabigatran can be approximated by its prolongation of routin...
Dabigatran, a direct thrombin inhibitor, is increasingly used clinically as one of the new oral anti...
Dabigatran etexilate, a pro-drug of a direct thrombin inhibitor, was approved a few years ago for no...
Background Direct oral anticoagulants (DOACs) are increasingly replacing vitamin K antagonists (VKA)...